MiMedx Group, Inc.
MDXGNASDAQHealthcareBiotechnology
As of Oct 15, 2026 close
- Market cap
- $693.16M
- P/E (TTM)
- 111.14
- Forward P/E
- 223.87
- Dividend yield
- -
- 52-week range
- $3.03$7.97
- Volume (live)
- -
- Avg. volume (3M)
- 1.13M
MiMedx Group (MDXG) Stock Price & Financial Analysis
MiMedx Group Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $4.66 - $4.88 |
|---|---|
| 52-Week High | $7.97 |
| 52-Week Low | $3.03 |
| Open | $4.76 |
| Volume (last close) | 1.33M |
| Average Volume (3M) | 1.13M |
| Revenue (TTM) | 355.17M |
|---|---|
| Net Income (TTM) | 6.24M |
| Free Cash Flow (TTM) | 40.58M |
| EPS (TTM) | $0.04 |
| Profit Margin | 1.76% |
| Operating Margin | 2.46% |
| Return on Equity (ROE) | 2.89% |
| Debt to Equity | 0.01 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 693.16M |
|---|---|
| Shares Outstanding | 147.80M |
| P/E Ratio (TTM) | 111.14 |
| Forward P/E | 223.87 |
| Price to Sales (P/S) | 1.95 |
| Price to Book (P/B) | 3.21 |
| EV/EBITDA | 24.67 |
| 50-Day MA | $4.54 |
|---|---|
| 200-Day MA | $4.41 |
| 1-Year Change | −29.26% |
Source: Market prices and company fundamentals. Data as of Oct 15, 2026. Data sources and methodology
MiMedx Group at a Glance
As of the Oct 15, 2026 close, MiMedx Group (MDXG) has a market capitalization of $693.16M. The stock trades at 111.1× trailing earnings, 223.9× forward earnings and 1.9× sales. Over the trailing twelve months it earned $6.24M on revenue of $355.17M (a 1.8% profit margin) and generated $40.58M of free cash flow. Revenue fell 2.4% year over year.
As of its latest reported balance sheet, it holds $135.84M in cash and securities against $1.50M of debt, a net cash position of $134.34M.
MiMedx Group does not currently pay a dividend.
The share price is down 29.3% over the past year. At $4.69 (the Oct 15, 2026 close) it sits within its 52-week range of $3.02 to $7.97, above its 200-day moving average of $4.41.
Based on 3 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $7.50, 59.9% above the Oct 15, 2026 close.
Frequently Asked Questions About MiMedx Group
What is the current stock price for MDXG?
As of the Oct 15, 2026 close, MDXG stock trades at $4.69. The 52-week range is $3.03–$7.97, with a day range of $4.66–$4.88.
What is the P/E ratio for MDXG?
As of the Oct 15, 2026 close, MiMedx Group's trailing twelve-month (TTM) P/E ratio is 111.1, meaning investors pay $111.1 for every $1 of annual earnings. The forward P/E is 223.9, reflecting analyst expectations for future earnings. MiMedx Group operates in the Healthcare sector.
Does MDXG pay dividends?
MiMedx Group does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for MDXG?
Based on ratings from 3 professional analysts over the last 90 days, the consensus for MDXG is Buy. The average 12-month price target is $7.50, a 59.9% upside from the Oct 15, 2026 close of $4.69.
What is the market cap of MDXG?
As of the Oct 15, 2026 close, MiMedx Group's market capitalization is $693.2M, classifying it as a small-cap company. MiMedx Group operates in the Healthcare sector within the Biotechnology industry.